Stay updated on Atezolizumab in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in Advanced NSCLC Clinical Trial page.

Latest updates to the Atezolizumab in Advanced NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page now includes a Locations section listing Orlando, FL and Pittsburgh, PA, replacing the previous Florida Locations and Pennsylvania Locations blocks, and shows a new Revision: v3.3.3.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.2 from v3.2.0; no study details are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page no longer displays the funding-status notice banner related to federal operations. This change does not alter the study details, eligibility criteria, interventions, or results endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check52 days agoChange DetectedNo additions or deletions were observed in the page content. The page continues to present the study details for NCT03014648 (atezolizumab in NSCLC) without notable changes.SummaryDifference0.4%

- Check81 days agoChange DetectedKey updates: version bump to v3.2.0 and the new government-operating-status notice; the old v3.1.0 tag was removed.SummaryDifference2%

- Check88 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in Advanced NSCLC Clinical Trial page.